Anyone with primary myelofibrosis, low risk, asymptomatic?

Posted by mahmoudbakry @mahmoudbakry, Apr 2 8:04pm

Is there anyone here suffer from PMF? Or whose doctor diagnosed him primary myelofibrosis with low risk, no symptoms, my doctor is very hesitant to give me the final stamp PMF officially, and he is worrying about whether to start treatment or not?
by the way he told me the Treatment is :Jakavi ruxolitinib

Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.

Hi, I was diagnosed with PMF CALR + Int. 2 back in March 2021. It took many avenues to confirm that I had the right diagnosis.
After AML and CLL were ruled out through MANY labs, I had to have an ultrasound of my spleen, an abdominal MRI, as well as a bone marrow biopsy once PMF was suspected. The bone marrow biopsy showed major scaring and the ultrasound and MRI revealed a very large spleen. This is how I was diagnosed.
I was then referred to a BMT/SCT physcian in the same area. After speaking with him, I also got a second opinion through MAYO clinic of Jacksonville, Fl. At that time of diagnosis, both transplant physicians said that my current trarmenr plan was right on target with starting with an aggressive clinical trial.
Neither suggested at the time that I needed a SCT right away so my main oncologist/hematologist started me on a clinical trial which included Jakafi combined with another drug. It was a rough and rocky road but I was able to tolerate it for about 22 months. Due to many circumstances and tolerability, I discontinued the clinical trial and stayed on just Jakafi. This drug has really helped in many ways since I was very sympathetic at time of diagnosis.
I hope this was helpful!😊
Kind regards,
Rene’

REPLY

@mahmoudbakry, you might also be interested in this related discussion:
- Primary Myelofibrosis: Continue watch & wait? 2nd opinion?
https://connect.mayoclinic.org/discussion/primary-myelofibrosis/
Have you considered getting a second opinion?

REPLY
Please sign in or register to post a reply.